{
    "laboratory_examinations": [
        {
            "procedure_name": "Lithium Blood Level",
            "date": "Not specified",
            "findings": "0.6 meq/liter (normal range not specified)",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Valproic Acid Blood Level",
            "date": "Not specified",
            "findings": "76 µg/ml (normal range not specified)",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Carbamazepine Serum Level",
            "date": "Not specified",
            "findings": "Initially 7.0 to 8.3 µg/ml, elevated to 10.8 µg/ml after introducing nefazodone, later reduced to 7.4 µg/ml after dosage adjustment.",
            "changes_over_time": "Carbamazepine levels increased after the introduction of nefazodone from 7.0-8.3 µg/ml to 10.8 µg/ml, then decreased to 7.4 µg/ml after reducing the dose."
        },
        {
            "procedure_name": "Carbamazepine Serum Level",
            "date": "Not specified",
            "findings": "Initially ranged between 5.2 and 6.2 µg/ml; elevated to 15.1 µg/ml after nefazodone treatment.",
            "changes_over_time": "Carbamazepine levels increased to 15.1 µg/ml 14 days after starting nefazodone; subsequently decreased to 5.8 µg/ml after dose reduction."
        }
    ]
}